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Abstract. Chiral p-nitrophenyl esters derived from the amino acid phenylalanine are cleaved by 
various histidine-containing tripeptides and higher oligopeptides as catalysts at a micellar interface. 
It is assumed that the oligopeptides adopt an internally hydrogen-bonded C7 conformation when they 
dissolve into the micellar hydrocarbon phase. Chiral recognition is attributed to the formation of a 
hydrogen bond in the micellar hydrocarbon phase between one enantiomer of the ester and the 
peptide. It is important for the activity that the imidazolyl NH moiety of the His residue remains in 
the aqueous phase. The hydrophilic/hydrophobic balance, which determines the location of each of 
the amino acid residues of the peptide in the two-phase system, can be controlled by varying the 
length and stereochemistry of the peptide chain and by attaching hydrophobic groups. The most 
selective catalyst is a tripeptide w'ith the structure C4H90C(0)-L-Phe-L-His-L-Leu. It cleaves the 
p-nitrophenyl esters of N-protected L- and D-phenylalanine with an enantioselective of k J k D ^  40. 
Further lengthening of the peptide chain with L-Leu and L-Ala residues and lengthening of the 
N-protecting group of the catalyst decreases the enantioselectivity down to k J k D ^  6 for the penta- 
peptide C ]2H 250C(0)-L-Phe-L-His-(L-Leu)3. The origin of these effects is discussed.
Introduction
Reactions in aqueous surfactant solutions are the subject of 
an increasing number of papers2'-12. The kinetics of these 
reactions resemble to some extent the kinetics of enzyme- 
catalyzed reactions. Recently, high (enantio-)selectivities, 
characteristic of enzyme-controlled reactions, have been 
described in a number of papers on micellar-catalyzed 
reactions. These papers deal with the- cleavage of chiral 
amino acid p-nitrophenyl esters by the imidazolyl moiety of 
histidine-containing oligopeptides2-12. Until recently, the 
origin of the observed enantioselectivities was not under­
stood. In our previous paper we presented a detailed model 
that explains these phenomena1. In the present paper, this 
model is refined and chiral recognition is improved.
In aqueous solution, the imidazolyl moiety is an active 
catalyst in the hydrolysis ofp-nitrophenyl esters. In the first 
step of this hydrolysis, the imidazolyl group is acylated. In 
the second, relatively slow step, the acylated imidazolyl 
intermediate is hydrolyzed and the free imidazolyl moiety is 
regenerated1. Upon increasing the substrate concentration, 
typical Michaelis-Menten kinetics are observed. At high 
substrate concentrations, the catalyst is completely acylated 
and the reaction rate is independent of substrate concen­
tration.
This paper describes the esterolytic activity and enantio­
selectivity of a number of imidazolyl-containing oligo­
peptide derivatives dissolved in an aqueous micellar solu­
tion. These peptides are listed in Chart 1, including their 
abbreviations. The nomenclature and conventions used fol­
low the recommendations of the IU PA C -IU B  Commission 
on Biochemical Nomenclature13,14. The imidazolyl moiety is 
part of the chiral amino acid residue L-histidine at the
2-position of the oligopeptide. In our previous paper1, we 
showed that, for a number of histidine-containing dipep­
tides, the highest enantioselectivity was obtained with 
L-phenylalanine in position 1. Consequently, in the higher 
oligopeptides that are presented here, this position 1 is 
always occupied by this amino acid residue. The C-terminal 
end is unprotected, which implies that, under the pH con­
dition used (pH 7.3), the carboxyl moiety is deprotonated 
and in its anionic form. The peptide chain of the L-Phe-L-His 
derivative is extended up to a pentapeptide using various L- 
and D-amino acid residues and the effect of these residues 
on the esterolytic activity and enantioselectivity was 
studied. The N-protecting group (R 'CO) of the peptide 
chain is of the alkyloxycarbonyl type, which proved to be 
the most effective protecting group1. The surfactant used is 
the chiral cationic surfactant (/^-N-hexadecyl-A^jV-dimethyl- 
-(a-methylbenzyl)ammonium bromide (R-surf 16, see
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5 . 2-i.-Phe-L-His 
S 12-L-Phe-L-His-Glv
S 12-L-Phe-L-His-L-Ala
S 12-L-Phe-L-His-L-But
S 12-L-Phc-L-His-L-Norval
5 . 2-L-Phc-L-His-L(or d)-Lcu 
S 12-L-Phc-L-His-L-Phc
S 12-L-Phc-L-His-L-Trp 
S 12-L-Phc-L-His-L-Thr 
S 12-L-Phe-L-His-L-Pro 
S )2-L-Phe-L-His-L-Ileu
5 . 2-L-Phe-L-His-L-Phegly
5 . 2-L-Phe-L-His-L-Asp 
S 2-L-Phe-L-His-L-Leu 
S 2-L-Phe-L-His-L-Ala 
S4-L-Phe-L-His-L-Leu 
S 4-L-Phe-L-His-L-Ala 
S 6-L-Phe-L-His-L-Leu 
S 6-L-Phe-L-His-L-AIa 
Z-L-Phe-L-His-L-Lcu
S 12-L-Phe-L-His-L-Leu-L (or d)-Lcu 
S 12-L-Phe-L-His-L- Ala-L-Lcu 
S I2-L-Phc-L-His-Gly-L-Lcu 
S I2-L-Phc-L-His-L-Lcu-L-Ala 
S t2-L-Phe-L-His-L-Ala-L(or D)-Ala
S I2-L-Phc-L-His-(L-Lcu)3
5 . 2-L-Phc-L-His-(L-Ala)3
5 . 2-L-Phc-L-His-NMA 
S4-L-Phc-L-His-A/MA
Chart 1. Catalysts.
Chart 2). This surfactant was chosen to study the effect of 
a chiral centre in the surfactant headgroup on the enantio- 
selectivity of the esterolytic reaction. The chiral substrates, 
which are shown in Chart 3, are TV-acyl /?-nitrophenyl esters 
of the amino acid L- or D-phenylalanine (C„-Phe-ONp).
It is our aim to understand the cause of the observed 
enantioselectivity and to rationalize the effects on reactivity 
and selectivity upon structural changes in catalyst and/or 
substrate. Attention is, therefore, focussed on the first step 
in the catalytic cycle, i.e., the acylation of the imidazolyl 
moiety. In this step, the enantioselectivity is expressed as 
the ratio of the rate constants obtained for this acylation 
step using L and D substrates: k { J k D. The deacylation step 
of the acylated imidazolyl moiety, regenerating the free 
imidazolyl group was not investigated.
Special attention was paid to the blank (background) 
reaction. It is generally assumed that the blank reaction in 
the presence and absence of the catalyst is identical. It will 
be shown that this assumption is valid only under certain 
conditions. If these conditions are not met, large errors can 
occur.
Results
Catalytic activity a n d  enantioselectivity o f  S ]2-L-Phe-L-His-L-  
(or D-) X
In Table I, the catalyc activities and enantioselectivity of 
tripeptide catalysts towards C 12-Phe-ONp ( l  and d ) in the 
presence of the surfactant R-surf 16 are listed. For compari­
son, the data of the dipeptide catalysts S 12-L-Phe-L-His and
Br
R ( or S ) - surf 16
Chart 2. Surfactant
— C*H—C —
O
C n-L ( or d ) -Phe-ONP: R3 = CH3 ( CH2 )n.2—  ; ( n = 2,4,7,12.16 )
Chart 3. Substrates
S ,2-L-Ala-L-His are also included1. In general, introducing a 
third amino acid residue at the 3-position of the catalyst 
appears to have little effect on the observed selectivity. An 
exception is S 12-L-Phe-L-His-L-Leu (entry 7) which exhibits 
an enhanced selectivity of k j k 0 = 23 when compared to 
the corresponding dipeptide catalyst (k j k D 16.6). Increase 
in hydrophobicity and size of the amino acid residue in the
3-position has no marked effect, up to a certain limit 
(entries 3-7). However, with the very bulky Phe residue, the
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rate and selectivity are considerably suppressed (entry 8) as 
if a critical point is passed. The catalysts with the very 
hydrophobic lie and Phg residues in the 3-position, whose 
side chains are both branched at Cp, also exhibit reduced 
activity and enantioselectivity (entries 9 and 10). However, 
with the Trp residue in the 3-position, which is the largest 
residue tested, the rates and enantioselectivity are not 
affected to any large extent (entry 11). Neither a proline 
residue, whose side chain is covalently attached to the 
amide nitrogen atom of the peptide backbone, nor a hydro­
philic threonyl residue has a large effect on the observed 
selectivity and activity (entries 12 and 13). From the results 
in Table I, it can be concluded that the reactivity of the 
imidazolyl group is reduced upon adding a third amino acid 
residue. The smallest reduction is observed for the 
S ,2-L-Phe-L-His-L-Asp catalyst, which has two unprotected 
C O O " moieties in the 3-position. The activity of this 
catalyst is by far the highest of all tripeptide catalysts 
examined here, although, its selectivity is somewhat 
reduced. It seems that the presence of a carboxylate moiety 
in close proximity to the imidazolyl group promotes the 
activity of the latter. Changing the chirality of the Leu resi­
due in the 3-position from L to D causes a dramatic drop in 
selectivity from 23 to 1.9 (entries 7 and 15). This loss of 
selectivity is the result of a six-fold reduction in activity 
towards the L substrate and a two-fold increase in activity 
towards the D substrate, i.e., changing L-Leu into D-Leu has 
an opposite effect on the rates towards both enantiomers. 
Interestingly, the presence of the achiral amino acid residue 
Gly in the 3-position does not reduce the selectivity (com­
pare entries 3, 7 and 15). The chirality of the surfactant 
molecules has no significant efffect on the rates and enan­
tioselectivity (entries 7 and 16), a fact that was also 
observed previously for a number of dipeptide catalysts'.  
This means that no specific interactions {e.g., n stacking of 
aromatic rings) exists between these surfactant molecules 
and the catalysts or substrate, resulting in chiral recogni­
tion. This can also be concluded from the fact that the 
enantioselective profile of the esterolytic reaction does not 
change when R-surf 16 is substituted by the surfactant cetyl- 
tributylammonium brom ide1. The only apparent of the sur­
factant molecules is to form micelles that provide an inter­
face at which the reaction can occur.
Table I Rale constants [ k u ohJ (d m 3 ■ mol ' • s ~ ])] and enantio­
selectivity ( k , J k D)  in the cleavage o f  C {2-Phe-ONp (L and D) by comi- 
celles o f  S i2-L-Phe-L-His-L- (or D-) X  and  R-surf 16a.
Catalyst k L kn k J k D
1 : S | 2-L-Ala-L-His 693 191 3.6
2: S l2-i.-Phe-L-His 6012 363 16.6
3: S , 2-L-Phe-L-His-Gly 2605 157 16.6
4: S 12-L-Phe-L-His-L-Ala 2420 145 16.7
5: S 12-L-Phe-L-His-L-Abu 2134 134 15.9
6 : S 12-L-Phe-L-His-L-Nva 2224 136 16.4
7: S )2-L-Phe-L-His-L-Leu 2319 100 23.2
8 : S , 2-L-Phe-L-His-L-Phe 948 89 10.7
9: S 12-L-Phe-L-His-L-Ile 535 66 8.1
10: S , 2-L-Phe-L-His-L-Phg 516 64 8.1
11 : S | 2-L-Phe-L-His-L-Trp 1866 102 18.3
12: S | 2-i.-Phe-L-His-L-Pro 1973 130 15.2
13: S 12-L-Phe-L-His-i.-Thr 2002 129 15.5
14: S 12-i.-Phe-L-His-L-Asp 3295 325 10.1
15: S | 2-L-Phe-L-His-L-Leu 417 224 1.9
16: S , 2-L-Phe-L-His-L-Leub 2490 105 23.7
11 Conditions: 0.08N1 Tris/HCl and 0.40M KC1; pH 7.3; T 25°C; 
solvent, acetonitrile/water, 3:97 (v/v); ccat 5*10 5M; ccstcr
1 • 1 0 - 5M; csurf 2.5- l t r 3M. b S-surf 16.
Fluorescence measurement on the S ]2-L-Phe-L-His-L-Trp 
catalyst✓
Fluorescence measurements on the S ,2-L-Phe-L-His-L-Trp 
catalyst under these reaction conditions show that the Trp 
side chain is in a relatively apolar environment. At an exci­
tation wavelength of Xcx 286 nm, the fluorescence emission 
maximum of the Trp side chain appears at Xcm 352 nm. This 
position is also observed in a 1,4-dioxane/water mixture of 
55:45 (v/v), demonstrating that the degree of hydration of 
the indolyl moiety in this catalyst at the micellar interface is 
similar, i.e., it is about 40 -50%  dehydrated. The same con­
clusion was derived from fluorescence measurements on the 
dipeptide catalyst S 12-L-Trp-L-His, i.e., the indolyl group is 
partially dehydrated but is still in contact with bulk w a te r1. 
Higher surfactant concentrations do not cause a further 
blue shift in the position of the emission maximum indi­
cating that this catalyst is completely micellar-bound at the 
applied surfactant concentration1.
Catalytic activity o f  S n-L-Phe-L-His-L-Leu and S n-L-Phe-L- 
-His-L-Ala catalysts
In this section, the length, n, of the hydrocarbon chain of 
the S„-L-Phe-L-His-L-Leu catalyst is varied from n = 2 to
12. The results obtained with the substrate C I2-Phe-ONP (L 
and d) are listed in Table II. In this Table, the data for the 
/V-benzyloxycabonyl- (Z-) protected catalyst are also in­
cluded. Upon increasing the length and thus the hydro- 
phobicity of the N-protecting group from n = 2 to 12, the 
reaction rate strongly increases. This enhanced reactivity 
reflects the fact that an increasing fraction of the catalyst is 
bound to the micelle where the substrate resides. The enan­
tioselectivity increases from S2 to S4 where it reaches a 
maximum (kL/k0 = 38.1) and decreases upon further chain 
lengthening.
Table 11 Rate constants f k a (ths/(dm 3 • mol 1 • s~ 1 )/ and enantio­
selectivity ( k , J k D) in the cleavage o f C i2-Phe-ONp (L and d )  by comi­
celles o f  S n-L-Phe-L-His-L-Leu (n = 2. 4, 6, 12) and  R-surf 16a.
Catalyst k L k J k D
AA G*  
(kcal/mol)
S.-L-Phe-L-His-L-Leu 157 15 10.5 1.39
S4-i.-Phe-i.-His-L-Leu 1257 33 38.1 2.16
S6-L-Phe-L-His-L-Leu 1544 59 26.2 1.93
S 12-L-Phe-L-His-i-Leu 2319 100 23.2 1.86
Z-i.-Phe-L-His-L-Leu 1284 32 40.1 2.19
11 Conditions as described in Table I.
The activities and selectivity of Z- and S4-protected 
L-Phe-L.-His-L-Leu catalysts do not differ significantly. Such 
behaviour was also observed for Z-L-Phe-L-His and 
S4-L-Phe-i.-His dipeptide catalysts1. This indicates that the 
R 1 moieties butyl and benzyl are sterically and hydrophobi- 
cally very similar in the present reaction 
Table III shows that a bell-shaped selectivity dependence 
on n is also observed for S„-L-Phe-L-His-L-Ala (n = 2, 4, 6 , 
12). However, the enantioselectivity is approximately 
25-30%  lower than for the S„-L-Phe-L-His-L-Leu catalysts. 
Although not investigated, it is likely that such bell-shaped 
selectivity curves will also be found for the other tripeptide 
catalysts listed in Table I. We repor ted 1 previously a similar 
but smaller effect in the S„-L-Phe-L-His series, with a maxi­
mum of k LIkD = 18.3 at n = 3. This means that the rela­
tively small effect on the selectivity observed when the ca ta­
lyst is extended with a third amino residue (Table I) is 
rather fortuitous and probably only occurs in the S l2_
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-protected scries. In the S4 series, the enantioselectivcity 
considerably increases from 18 to 38 by adding l- L cu as a 
third residue.
Table III  Rate constants f k (lolJ ( d m y • mol~ 1 • s~  1)] and enantio- 
seiectivity (kLf k n) in the cleavage o f  C l2-Phe-ONp ( l  and n) by comi- 
celles o f  Cn-L-Phe-L-His-L-Ala (n = 2. 4. 6, 12) and  R- s w f  16*.
Catalyst A-'d k \Jk  D
AA G*  
(kcal/mol)
So-L-Phe-L-His-L-Ala 128 14 9.1 1.31
S4-L-Phe-L-His-i.-Ala 1190 46 25.9 1.93
S(1-L-Phe-L-His-L-Ala 1749 89 19.7 1.76
S 12-L-Phe-i.-His-L-Ala 2420 145 16.7 1.67
A Conditions as described in Table I.
Catalytic activity o f  S ^ -L -P h e-L -H is-L -L eu  towards Cn-Phe-
-ONp
Table IV shows the activities and enantioselectivity 
obtained with the S 12-L-Phe-L-His-L-Leu catalyst towards 
the C„-Phe-ONp substrates (n = 2, 4, 7, 12, 16). Increasing 
the length of the acyl chain increases both the activity and 
selectivity. The enhanced activity will be due to increased 
binding of the substrate to the micelle. Complete binding is 
achieved at approximately n = 12. The applied catalyst, 
S l2-L-Phe-L-His-L-Leu, is also completely bound to the 
micelle. Upon increasing n in the substrate, the selectivity 
approaches a limiting value of &L/fcD = 23 at n = 12. A dif­
ferent effect on selectivity was observed for the S„ chain in 
the catalyst, which displays a clear optimum at S4.
Table IV  Rate constants f k a ohsl(dm y • mol~ 1 • s~ ])] and enantio­
selectivity (kL/ k D) in the cleavage o f  Cn-L- (and d - ) Phe-ONp (n =  2,
4, 7. 12, 16) by comicelles o f  S [2-L-Phe-L-His-i.-Leu and  R-surf 16a.
Ester k L k J k D
AA G*  
(kcal/mol)
C .-Phe-ONp 328 43 7.6 1.20
C4-Phe-ONp 669 75 8.9 1.29
C 7-Phe-ONp 1559 90 17.3 1.69
C l2-Phe-ONp 2319 100 23.2 1.86
C,<r Phe-ONp 2320 106 21.9 1.83
A Conditions as described in Table I.
Activity and enantioselectivity o f  tetra- and pentapeptide cata­
lystsO'
Table V shows how the activity and enantioselectivity of the 
esterolytic reaction is affected when the peptide chain of the 
catalyst is further extended with L and/or D residues. For 
comparison, the data  of the corresponding di- and tri­
peptide catalysts are also included. Increasing the peptide 
chain length of the S ,2-L-Phe-L-His catalyst with L-Ala or 
L-Leu residues causes a dramatic drop in activity. The effect 
is considerably larger for the more hydrophobic L-Leu resi­
due (entries 1-4) than for the smaller L-Ala residue 
(entries 1, 5-7). The enantioselectivity remains unaffected 
up to the tripeptides or even slightly increases (for the S l2- 
-L-Phe-L-Leu catalyst), as noted above. Upon further chain 
lengthening, the enantioselectivity also rapidly decreases. 
The tetrapeptide catalysts with L-Leu-L-Ala and L-Ala- 
-L-Leu in the 3- and 4-positions (entries 8 and 9) display 
intermediate activities and enantioselectivity in comparison
Table V Rate constants [ka ohJ (d m y • mol~ 1 • s~ x)] and enantio­
selectivity ( k ,J k D) in the cleavage o f  C ]2-Phe-ONp ( l  and n) by comi­
celles o f  His-containing oligopeptides and  R-surf 16iX.
Catalyst k L /d k J k D
1 : S ,2-L-Phc-L-His 6012 363 16.6
2: S ,2-L-Phe-L-His-L-Leu 2319 100 23.2
3: S l2-L-Phe-L-His-L-Leu-L-Leu 156 33 4.7
4: S | 2-L-Phe-L-His-L-Leu-L-Leu-L-Leu 89 15 5.9
5: S , 2-L-Phe-L-His-L-Ala 2420 145 16.7
6 : S l2-L-Phe-L-His-L-Ala-L-Ala 809 77 10.5
7: S , 2-L-Phe-L-His-L-Ala-L-Ala-L-Ala 349 46 7.6
8 : S l2-L-Phe-L-His-L-Leu-L-Ala 345 48 7.2
9: S , 2-L-Phe-L-His-L-Ala-L-Leu 577 62 8.5
10: S , 2-L-Phe-L-His-L-Leu-D-Leu 333 26 12.8
11: S , 2-L-Phe-L-His-L-Ala-D-Ala 1510 69 21.9
a Conditions as described in Table I.
to the catalysts with L-Leu-L-Leu and L-Ala-L-Ala in these 
positions.
Interestingly, the tetrapeptide catalyst with L-Leu-D-Leu 
(entry 10) in the 3- and 4-positions exhibits much higher 
enantioselectivity than the catalyst with the equally hydro- 
phobic L-Leu-L-Leu sequence (entry 3). A similar effect is 
observed for the tetrapeptide catalysts with L-Ala-L-Ala and 
L-Ala-D-Ala in the 3- and 4-positions (entries 6 and 11).
These differences must be caused by a difference in the 
shape of the diastereomeric catalysts.
Catalytic activity o f  S 4- and S  ¡2-L-Phe-L-His methylamide
Table VI shows the activities and selectivity obtained with 
S4- and S 12-L-Phe-L-His-NMA. In these catalysts, the car­
boxyl groups are protected by methylamine. The activities 
and enantioselectivity are strongly reduced compared to the 
corresponding di- or tripeptide catalysts which have an 
unprotected carboxyl group (see Tables I, II and III). This 
almost total collapse of the observed rates and severe sup­
pression of the enantioselectivity cannot be attributed to a 
steric effect of the NMA-protecting group, as this group is 
smaller than any of the amino acid residues in the 3-position 
of the tripeptide catalysts. The catalytic activity of S 12-l-  
-Phe-L-His-NM A, for instance, should be compared with the 
S 12-L-Phe-L-His-Gly catalyst (Table I, entry 3). The struc­
tural difference is that, in the latter catalyst, one hydrogen 
atom of the N M A  moiety is replaced by a carboxylate 
group. These data indicate that the proximity of the car­
boxylate group increases the activity of the imidazolyl 
moiety.
Table VI Rate constants [k (l ohs/(dm 3 • mol~ 1 • s~ ])] and enantio­
selectivity (kL/ k n) in the cleavage o f  C ]2-Phe-ONp ( l  and D) by comi­
celles o f S 4/ S ]2-L-Phe-L-His-NMA and  R-surf 16a.
Catalyst k\_ ko k J k D
S4-L-Phe-L-His-NMA 62 8 7.8
S 12-L-Phe-L-His-NMA 149 26 5.7
a Conditions as described in Table I.
Solvent isotope effect and apparent p K cl o f  the imidazolyl 
moiety
Table VII shows the solvent deuterium kinetic isotope effect 
for the cleavage of C l2-Phe-ONp by various histidine-
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containing catalysts. The kinetic isotope effects do not differ 
significantly for both enantiomers of the substrate. All 
values of &N//cD are in the range 1 . 1 - 1 .5, which indicates 
that proton transfer does not take place in the rate-deter- 
mining step, i.e., the reaction is not general base-catalyzed16.
Table VII Solvent kinetic isotope effects for the cleavage o f  
C l2-Phe-ONp ( l  and n )  by comicelles o f  His-containing peptides and 
R -surf 16*.
Catalyst k\-i/ko ( l ) k n / k o  (d)
S 12-L-Phe-L-His 1.1 1.2
S 12-i.-Phe-L-His-L-Leu 1.5 1.5
S 12-L-Phe-L-His-L-Asp 1.4 1.5
S l2-L-Phe-L-His-L-Leu-L-Leu 1.1 1.2
Conditions as described in Table I.
In Table VIII, the apparent pK a values are given of two 
catalysts that are bound to micelles of Z?-surf-16. The p K a 
values of the S2 compounds were measured in the absence 
of surfactant. It was impossible to measure the p K a of the
S , .-protected catalyst in the absence of surfactant because 
self-aggregation occurred. Comparison of the p K a values in 
the presence and absence of surfactant gives the effect of 
micellar adsorption on the p K a. The p K a (ImH f ) of 6.9 
measured in the absence of surfactant is a normal value for 
N-protected histidine17. The apparent pK a (ImH 1 ) values 
of the micellar-bound catalysts are approximately 0.5 pK.A 
unit lower, which is to be expected for cationic micelles18,19. 
Due to the positive charge of the micellar surface, protona- 
tion of the imidazolyl group is impeded (field effect). The 
positively charged surface will also attract hydroxide ions 
from the solution, i.e., the local hydroxide ion concentration 
(and hence the pH) at the micellar surface is higher than in 
the bulk aqueous phase. Consequently, the imidazolyl group 
appears to deprotonate at a lower pH.
Table VIII Apparent p K tl values o f  the imidazolyl moieties in various 
catalysts in the presence ( S l2) and absence (S2) o f  R-surf 16a.
Catalyst pA:a (ImH + )
S2-L-Phe-L-Hisb 6.9
S,-L-Phe-L-His-L-Leub 6.9
S 12-L-Phe-L-His 6.4
S I2-L-Phe-L-His-L-Leu 6.3
a Conditions: 0.40M KC1; ccat 2- 1 0 " 4M; csurf 1 • 10“ 2M. b In 
the absence of surfactant.
The blank reaction
In order to calculate the catalytic activity of a catalyst (kcal) 
from the observed reaction rate (rate constant kobs), the 
magnitude of the blank or background reaction (A:bl) must 
be known (kcal = kobs ”  ^bi)- The blank reaction rate is 
determined in the absence of catalyst, and it is assumed 
that, in the presence of the catalysis, this blank reaction is 
unaffected. However, it will be demonstrated that this 
assumption is only valid under certain conditions.
Cationic micelles greatly accelerate hydrolysis of the 
adsorbed substrates. This effect is due to the attraction of 
hydroxide ions from the solution, i.e., the local hydroxide 
ion concentration or local pH at the micellar surface is 
higher than the pH in the bulk aqueous solution. In spite of 
the presence of a buffer, the micellar surface is not buf-
Q
0
0.0 0.1 0.2 0.3 0.4
c /M  
KCl
Figure 1. a) The reduction o f the blank reaction o f C ]2- d - 
-Phe-ONp by S X2-L-Phe-ONa (5-10 *M) as a function 
o f the KCl concentration. cslir/2.5 m M ; cester 1 • 10~5M ;  c Tris
0.02M ; pH  7.3. b) The enantioselectivity (kL/ kD) o f the 
reaction between the S {2-L-Phe-L-H is-L-Leu  catalyst and 
C l2-Phe-ONp as a function o f the KCl concentration. Condi­
tions as described for Figure la ;  ccat 5 • 10~5M. 1 ) Uncorrected 
blank reaction. 2) Blank reaction corrected with the aid o f  
Figure la.
fered18,19. Most catalysts used are anionic amphiphilic 
molecules that bind tightly to the micelles. Consequently, 
the micellar charge density is reduced and fewer hydroxide 
ions will be bound. This results in a reduction in the rate of 
spontaneous ester hydrolysis. In order to investigate this 
effect, we used the catalytically inactive model compound 
iV-(dodecyloxycarbonyl)-L-phenylalanine sodium salt ( S I2-l- 
-Phe-ONa) at a concentration similar to that of our ca ta­
lysts and determined the reduction of the blank hydrolysis 
(A£b|) of C ,2-D-Phe-ONp at various concentrations of 
added KCl (pH 7.3, 0.02 mol/dm3 Tris/HCl). The results are 
shown in Figure la. The observed reduction in rate con­
stant is expressed in the same units as the catalytic rate 
constants in the Tables and their magnitudes can be directly 
compared. At cKC1 = 0, the addition of the model compound 
causes a reduction of A:b, from 1112 to 1012 
dm 3 • mol 1 • s " '. In the presence of 0.4 m o l - d m " 3 KCl, 
the blank reaction is reduced from A:bl = 25 to k M = 22 
d m 3 • mol ~ 1 • s “ l. At low KCl concentrations, many hydrox­
ide ions are bound to the micelles. Consequently, binding 
of the negatively charged model compound replaces many 
hydroxide ions and the blank reaction rate is considerably 
reduced. At high salt concentrations (cc ,~ >  0.3 mol/dm3), 
the micelles only bind C l “ ions at their surface which are 
partially replaced by the model compound. The blank 
reaction rates now remain almost unaffected. It should be 
noted that the reduction of the blank reaction rate at low 
KCl concentration (A/cbI = -  100 d m 3 • mol “ 1 • s ~ 1) be­
comes of similar magnitude as or is even larger than the 
catalytic reaction rates towards the D substrates (A:D is 
approximately 100 dm 3 • mol ~ 1 • s ” 1). This means that if we 
calculate k D = kobs -  k bl, with the assumption that kM is 
unaffected by the presence of the catalyst, we severely 
underestimate the magnitude of k D since we use a value for 
kb] that is too large. The underestimation of A:L, which gen­
erally has a much larger value than A/cbl, is of minor 
importance. The result is that the enantioselectivity of a
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catalyst { k j k n ) is severely overestimated. This artifact is 
shown in Figure lb for the S 12-i-Phe-L-His-i.-Leu catalyst 
as a function of the added amount of KC1. It can be con­
cluded that the assumption A:b, (in the presence of ca ta­
lyst) = A:b, (in the absence of catalyst) in the present system 
is only valid at high ionic strength (cc l - >  0.3 mol/dm3). 
High enantioselectivity has been reported due to the above 
described artifact9' 11,20,2The experiments described in this 
paper were carried out in the presence of 0.4 mol/dm3 KC1, 
which means that the calculated enantioselectivity values 
are reliable.
Non-ionic molecules that adsorb to the micelles and cause 
an increase in surfactant headgroup-headgroup distance 
will also reduce the charge density at the micellar interface. 
Consequently, fewer OH " ions will be bound, resulting in a 
reduction in the blank reaction rate.
Discussion
A micellar solution is a two-phase system consisting of an 
aqueous phase and a hydrocarbon-like micellar pseudo­
phase (Figure 2a). When our peptide catalysts dissolve into 
the micellar hydrocarbon phase, the polar amide groups will 
be dehydrated, which is very unfavorable. To compensate 
for this dehydration, the amide groups will try to form 
internal hydrogen bonds. Since a completely internally 
hydrogen-bonded conformation is not possible for our pep­
tides, the resulting folded peptide chain has an amphiphilic 
character. To what extent the peptide chain will dissolve 
into the micellar hydrocarbon phase will be determined by 
the hydrophilic/hydrophobic balance of the peptide chain. 
Peptides shift their preference to the apolar phase if they 
adopt the internally hydrogen bonded C7- or y-turn confor­
mation22. A seven-membered ring including the H atom is 
formed (Figure 2b). In the following, we assume that our 
small peptide catalysts also adopt this C 7 conformation, 
when they dissolve into the micellar hydrocarbon phase, 
forming as many intramolecular hydrogen bonds as possible 
(Figure 2 b).
As explained in our first p ap e r1, the NH group of the Phe 
residue in position 1 of the catalyst forms an intermolecular 
hydrogen bond with the amide CO moiety of the L sub­
strate, when the imidazolyl moiety of the His residue 
attacks the ester group to form the tetrahedral intermediate 
(Figure 2c, see also Figure 3a). This hydrogen bond con­
tributes to the stability of the transition state when it is 
formed in the apolar micellar hydrocarbon phase. This sta­
bilizing hydrogen bond is not formed in the diastereomeric 
intermediate with the D substrate. Consequently, the 
reaction rate towards the l  substrate is much higher. When 
residue 1 in the catalyst is less hydrophobic, the transfer of 
the NH moiety to the micellar hydrocarbon phase is incom­
plete and the hydrogen bond with the L ester becomes less 
favorable, resulting in a reduction in the reaction rate 
(compare entries 1 and 2 in Table I). This feature was dis­
cussed in our previous p ap e r1.
In the tetrahedral intermediate, a positive charge has devel­
oped on the imidazolyl moiety which is not present in the 
ground state (Figures 2c and 3). In order to stabilize this 
positive charge, the imidazolyl moiety requires a polar 
environment: the imidazolyl NH group must remain in the 
aqueous phase. In order to prevent the imidazolyl moiety 
from dissolving into the micellar hydrocarbon phase, the 
imidazolyl NH moiety must be structurally connected to the 
very hydrophilic carboxylate moiety. In liquid water at 
room temperature, such a connection is possible if the dis­
tance between the two groups (d)  does not exceed the space 
required for two hydrogen-bond water molecules, or
a)
c7
<>o
Figure 2. a) Schematic representation o f a peptide catalyst 
adsorbed at the micellar interface. The amide groups o f the 
peptide chain in the aqueous phase are hydrated, resulting in a 
flexible chain. The amide groups in the micellar hydrocarbon 
phase are internally hydrogen-bonded, resulting in a rigid con­
formation. b) Structural formula o f a peptide catalyst that has 
adopted the 2 7 helix. The internal C7 hydrogen bonds are 
shown as dotted lines. The arrow indicates the N H  group that 
is not internally hydrogen bonded and a potential hydrogen- 
bond donor, c) The tetrahedral intermediate formed by the 
S n-L-Phe-L-His catalyst and the Cn-L-Phe-ONp substrate. H y­
drogen bonds are shown as dotted lines.
approximately 7-8 A (Figure 2c)23,24. If this distance is 
larger, the hydration of the imidazolyl and that of the car­
boxylate moiety become independent. The imidazolyl 
moiety can dissolve in the apolar micellar hydrocarbon 
phase and become a less effective catalyst. This carboxylate- 
imidazolyl interaction in combination with the above pro­
posed hydrogen bonds affords a satisfying explanation for 
our observations.
Figure 3 shows the tetrahedral intermediates of a number of 
catalysts, which have adopted the C 7 conformation. This 
Figure further indicates whether the imidazolyl group falls 
within the hydration mantle of the C-terminal carboxylate 
group {d < 8 A) or not (d > 8 A). The distance d is deter­
mined with the aid of CPK space-filling models.
Figure 3a gives the intermediate for the reaction with the 
S„-L-Phe-L-His catalyst. For both the l  and D substrates, 
the imidazolyl NH moiety falls within the hydration mantle 
of the carboxylate group. Consequently, the activity towards 
both substrates is relatively high. However, due to the addi­
tional hydrogen bond with the L substrate, the activity 
towards this enantiomer is higher { k J k D = 16.6; Table I, 
entry 2 ).
Figure 3b shows the intermediate for the L substrate with 
the S„-L-Phe-L-His-L-Leu catalysts. Transfer of the Leu 
residue to the micellar phase is facilitated because of 
dehydration of its NH group is compensated for by hydro­
gen bonding to the Phe C = 0 .  In the micellar phase, the Leu 
NH moiety forms a hydrogen bond with the L substrate and 
chiral recognition will improve (up to k J k D = 40; Table II). 
These two internally hydrogen-bonded groups are located 
on both sides of the His residue (see also Figure 2b in which
C< X)
flexible hydrated 
peptide chain
COO Water
interface
Micelle
rigid internally hydrogen 
bonded peptide chain
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Figure 3. S ch em a tic  representation o f  the te trahedral inter­
m edia tes  fo r m e d  by the l  substrate a n d  a) S n-L-Phe-L-H is (the 
in term ediate with the D substrate is also show n); b) S n-L-Phe-L- 
-H is -L -L e u ; c) S U-L -P he-L -H is-D -L eu; d) S n-L-Phe-L-H is-L-X-  
-L-X;  e) S n-L -P he-L -H is-L -X -D -X ; f )  S n-L-Phe-L-H is-L-X-L-  
-X-L-X.  The distance between the carboxyla te  group a n d  the 
im idazo ly l N H  m oiety  is given by  d. A ll catalysts are shown in 
the 2 7-helical conformation.
R2 = C H 2-Im) and their dehydration will cause a more 
hydrophobic environment for the imidazolyl moiety. 
Consequently, the reaction rate decreases if compared to 
the corresponding dipeptide (Table I, entries 2 and 7 and 
Table II, entry 4). The distance between the imidazolyl NH 
moiety and the carboxylate group has increased but is still 
smaller than 8 A. This will prevent the imidazolyl moiety 
from completely dissolving into the micellar hydrocarbon 
phase. However, if the third residue in the catalyst becomes 
too hydrophobic (Phe, lie, Phg; Table I, entries 8-10), the 
imidazolyl moiety will tend to dissolve completely into the 
micellar hydrocarbon phase and the reaction rate will be 
suppressed further. The Trp residue does not promote the 
transfer of the imidazolyl moiety to the micellar hydro­
carbon phase because the hydrophilic NH group of the 
indolyl moiety prefers to remain hydrated (Table I, 
entry 11). A similar resistance of the Trp residue to dissolve 
into the micellar hydrocarbon phase was also observed in 
our previous paper with Trp in the 1-position1.
Figure 3c gives the intermediate for the S„-L-Phe-L-His- 
-D-Leu catalysts. Here, the imidazolyl NH group just falls 
outside the hydration mantle of the carboxylate moiety 
( ¿ > 8  A) and the imidazolyl moiety will tend to dissolve 
into the micellar hydrocarbon phase. Consequently, the 
activity towards the L substrate and the enantioselectivity 
are strongly reduced (Table I, entry 15).
Figure 3d shows the intermediate for the L substrate and 
the S„-L-Phe-L-His-L-X-L-Y catalysts. The imidazolyl NH
moieties fall clearly outside the hydration mantle of the car­
boxylate group and the imidazolyl moieties will tend to dis­
solve into the micellar hydrocarbon phase. Consequently, 
the activities towards the L substrate and the enantio- 
selcctivities are strongly reduced. The effect is much larger 
for the more hydrophobic amino acid residues ( l -X -l-Y  = 
L-Leu-L-Leu; Table V, entry 3) than for the less hydro­
phobic residues ( l -X -l-Y  = L-Ala-L-Ala; Table V, entry 6 ). 
The effect is intermediate when l-X -l-Y  = L-Leu-L-Ala or 
L-Ala-L-Leu.
Figure 3e shows the tetrahedral intermediates for the L sub­
strate and the S„-L-Phe-L-H is-L-X -D -X  catalysts. Changing 
the terminal residue in the catalyst from L into D brings the 
imidazolyl NH moiety just within the hydration mantle of 
the carboxylate group ( ¿ / < 8 A). Consequently, both the 
activity towards the L substrate and the enantioselectivity 
increase (compare Table V, entries 3 and 6 with entries 10 
and 11). However, it should be noted that particularly when 
X = Leu, the reaction rates are low. This indicates that the 
hydrophobic/hydrophilic balance is such that the imidazolyl 
moiety tends to dissolve into the micellar hydrocarbon 
phase despite the proximity of the carboxylate group. 
Figure 3f shows the tetrahedral intermediate or the L sub­
strate and the S„-L-Phe-L-His-L-X-L.-X-L-X catalysts. In­
creasing the peptide chain of the catalyst with a 5th residue 
further increases the distance between the carboxylate resi­
due and the imidazolyl moiety (rf> > 8  A). If X becomes 
more hydrophobic, the tendency for the imidazolyl group to 
dissolve into the micellar hydrocarbon phase increases and 
the reaction rates decrease.
The S„-L-Phe-L-His-NMA catalysts (Table VI) lack the very 
hydrophilic carboxylate group. Consequently, the imidazolyl 
moiety can easily dissolve into the micellar hydrocarbon 
ph ase. This causes a large decrease in activity and enantio­
selectivity.
Tables II and III show that, in order to obtain maximum 
enantioselectivity, S„ in the catalysts must have optimum 
hydrophobicity. This behaviour is typical for an amphiphilic 
transition state in a two-phase hydrocarbon/water system. 
A shift in the hydrophobic/hydrophilic balance of a transi­
tion state affects its distribution between the two phases 
(which part dissolves into the micellar hydrocarbon phase 
and which part will remain in the aqueous phase), as already 
shown above. Increasing the hydrophobicity from S2 to S4 
promotes transfer of the NH moiety of the Phe residue to 
the micellar hydrocarbon phase. Consequently, the enantio­
selectivity increases. If the S„ group becomes more hydro- 
phobic, the effect levels off more for the L than for the D 
enantiomer, inasmuch as the transition state of the former 
is less hydrophilic because of its additional hydrogen bond. 
Consequently, the enantioselectivity is reduced.
Optimum hydrophobicity is not observed for the C„ group 
of the ester (Table IV). The hydrophobicity of C„ of the 
ester affects its distribution between the aqueous phase and 
the micellar hydrocarbon phase. The more hydrophobic C„ 
becomes, the greater the tendency of the ester to dissolve 
into the micellar hydrocarbon phase. At a certain point, the 
ester is completely dissolved into the micellar hydrocarbon 
phase. In the micellar hydrocarbon phase, the affinity of the 
amide CO group of the L enantiomer of the ester to form a 
hydrogen bond with the NH group of the Phe residue in the 
catalyst is at its maximum. Consequently, the enantio­
selectivity increases up to a limit value.
Experimental
General remarks
Thin-layer chromatography (TLC) was performed on silica gel 
(Merck DC-Plastikrolle, Kieselgel 60 F 2M) and detection was
d »  8 Â
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effected by ultraviolet light or iodine. Column chromatography was 
performed with silica gel (Merck Kiesclgel 60, 230-400 mesh). Sol­
vents and reagents were of  analytical grade. The preparation of the 
surfactant solutions with and without catalyst is described else­
w here1. The kinetic measurements  were carried out as described in 
Ref. 1. Elemental analyses were made from the final products and 
were all in good agreement with the calculated values.
Synthesis
N-(Dodecycloxycarbonyl)-(L-phenylalanyl)-L-histidine ( S l2-L-Phe-L- 
-H is-O H ); N-(dodecyloxycarbonyl)-L-alanyl-L-histidine ( S l2-L-Ala-L- 
-His-OH). The syntheses of these compounds are described in our 
previous p a p e r1.
N-(Dodecycloxycarbonyl)-(L-phenylalanyl)-L-histidyl-L- (or n-) X-OM e
(S  X2-L-Phe-L-His-X-OMe). H-X-OMe-HCI (X = amino acid) was 
coupled to /V-(dodecycloxycarbonyl)-(L-phenylalanyl)-L-histidine 
in D M F  with the aid of 1,3-dicyclohexylcarbodiimide according to 
a published m ethod25*26. This method can cause some racemi- 
zation of  the histidyl residue but the diastereomers can be removed 
by chromatography. The crude product was purified by column 
chromatography (Silica 60, eluent chloroform/methanol,  15:1 v/v) 
and recrvstallized from acetone. TLC: /?, 0.3 (silica chloroform/ 
methanol,  10:1 v/v) for all compounds. Traces of diastereomers 
that were formed by racemization of the histidyl residue showed an 
R f value on TLC around 0.25. These impurities were absent in the 
purified final products. 1R (KBr): 1745 (CO ester), 1690 (CO car­
bamate), 1650 (CO amide) c m - 1 . For individual compounds,  
'H N M R  (CDCl,) ,  [a]d /(c  1.0, methanol),  m.p./°C and yield/% 
are:
S , -,-L-Phe-L-His-Gly-OMe: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
(C H ,) ,„ ) ;  3.1 (2 x d (dist), 2 x 2 H ,  C H ,  (His) and C H ,  (Phe)); 3.7 
(s, 3H, O C H ,) ;  3.85 (s, 2H, C H 2 (Glyj); 3.95 (t, 2H, C H , 0 ) ;  4 .3 -
4.9 (m, 2H, CH (Phe) and CH (His)); 5.5 (d, 1H, NH (carbamate));  
6.75 and 7.45 (2 x s, 2 x 1H, 2 x CH (Im)); 7.2 (s, 5H, ArH); 7.3 
and 7.7 (2 x d, 2 x 1H, 2 x NH (amide)); 8.7 (s (br), 1H, NH (Im)) 
ppm; - 2 2 . 0 ° ;  150.0; 56.
S , -,-L-Phe-L-H,is-L-A la -0  M e : 8 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
( C H , ),(,); 1.45 (d, 3H, C H ,  (Ala)); 3.1 (2 x d (dist), 2 x 2 H ,  C H .  
(Phe) and C H 2 (His)); 3.7 (s, 3H, O C H ,) ;  4.0 (t, 2H, C H .O ) ;
4 .2 -4 .8 (m, 3H, 3 x CH); 5.5 (d, 1H, NH (carbamate));  6.8 and' 7.5 
(2 x s, 2 x 1H, 2 x CH (Im)); 7.3 (s, 5H, ArH); 7.7 and 7.8 ( 2 x d ,  
2 x  1H. 2 x  NH); 9.0 (s (br), 1H, NH (Im)) ppm; - 3 1 . 8 " ;  149.4; 
64.
S n -L-Phe-L-His-L-Abu-OMe: 5 0.9 (2 x t, 2 x 3H, 2 x C H ,) ;  1.3 (m, 
22H, (C H , ) I0 and C H ,  (But)); 3.1 (2 x d (dist), 2 x 2H, C H ,  (Phe) 
and C H 2 (His)); 3.7 (s, 3H. O C H ,) ;  4.0 (t, 2H, C H .O ) ;  4.2-4.S (m, 
3H. 3 x C H ) ;  5.5 (d, 1H, NH (carbamate));  7.7 and 8.4 ( 2 x s ,
2 x 1H, 2 x CH (Im)); 7.25 (s, 5H, ArH); 7.6 and 7.8 (2 x d, 2 x 1H, 
2 x N H ) ;  8.2 (s (br), 1H, NH (Im)) ppm; - 2 5 . 8 ° ;  139.4; 61. 
S l2-L-Phe-L-His-L-Nva-OMe: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of the S ]2-L-Phe-L- 
-His-L-But-OMe compound; — 23 .0 ' ;  112.8; 66 . 
S^-L-Phe-L-His-L-Leu-OM e: 5 0.9 (m, 9H, 3 x C H ,) ;  1.3 (m, 23H, 
( C H , ) 10 and C H .C H  (Leu)); 3.1 (2 x d (dist); 2 x 2 H ,  C H ,  (Phe) 
and C H ,  (Hist)); 2.65 (s, 3H, O C H ,) ;  4.0 (t, 2H, C H .O ) ;  4.2-4.9 
(m, 3H, 3 x C H ) ,  5.4 (d, H, NH (carbamate));  6.7 and 7.4 ( 2 x s ,  
2 x  1H, 2 x  CH (Im)); 7.2 (s, 5H, ArH); 7.5 and 7.8 ( 2 x d ,  2 x  1H,
2 x N H ); 8.0 (s (br), 1H, NH (Im)) ppm; -  19.5°; 84.0; 68 .
S ,n-L-Phe-L-His-L-Phe-OMe: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
( C H , ) 10); 3.0 (m, 6 H, 3 x C H X H ) ;  3.65 (s, 3H, O C H ,) ;  4.0 (t, 2H, 
O C H ,) ;  4.2-4.9 (m. 3H, 3 x CH); 5.5 (d, 1H, NH (carbamate));  7.2 
(s, 10H, 2 x ArH); 6.7 and 7.4 (2 x s, 2 x 1H, 2 x CH (Im)); 6.8 and
7.8 ( 2 x d ,  2 x l H ,  2 x N H ) ;  8.4 (s (br), 1H, NH (Im)) ppm; 
- 2 2 . 4 ° ;  128.7; 54.
S^-L-Phe-L-His-L-Trp-OMe: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
( C H , ),«,); 3.0 (m, H. 2 x C H X H ) ;  3.2 (d, 2 H, C H .  (Trp)); 3.65 (s, 
3H, O C H ,); 3.9 (t. 2H, C H .O ) ;  4.2-4.9 (m, 3H, 3 x C H ) ;  5.6 (d, 
1H, NH (carbamate));  6.7 and 7.3 ( 2 x s ,  2 x  1H, 2 x CH (Im));
6 .8-7.7 (m, 10H, ArH and 5 x CH (indolyl)); 7.4 and 7.7 ( 2 x d ,
2 x 1H, 2 x NH);  9.1 (s, 1H, NH (indole)) ppm; - 2 1 . 5 ° ;  109.7; 58. 
S^-i.-Phe-L-His-L-Ile-OMe:  5 0.9 (m, 9H, 3 x C H , ) ;  1.3 (m, 23H, 
(CH,) ,«  and C H C H ,  (lie)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  (His)); 
3.65 (s, 3H, O C H ,) ;  3.95 (t, 2H, C H .O ) ;  4.2-5.0 (m, 3H, 3"x CH); 
5.6 (d, 1 H, NH (carbamate));  6.65 and 7.35 (2 x s, 2 x 1H, 2 x CH 
(Im)); 7.2 (s, 5H, C6H 5); 7.7 ( 2 x d ,  2 x  1H, 2 x N H ) ;  8.1 (s (br), 
1H, NH (Im)) ppm; - 8 .6 °; 79.8; 51.
S X^ -L-Phe-L-His-L-Pro-OMe: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
C H , ) 10); 2.0 (m, H, 2 x C H ,  (Pro)); 3.0 (2 x d (dist), 2 x 2H, C H ,  
(Phe) and C H ,  (His)); 3.7 (s, 3H, O C H ,) ;  3.95 (t, 2H, C H , 0 ) ;  4.4 
(m, 2 x 1H, 2 x C H ); 4.9 (q (dist), 1H, CH); 5.6 (d, 1H, NH (car­
bamate)); 6.8 and 7.5 ( 2 x s ,  2 x  1H, 2 x CH (Im)); 7.2 (s, 5H, 
ArH); 7.4 (d, 1H, NH);  7.8 (s (br), 1H, NH (Im)) ppm; - 3 9 . 0 ° ;  
57.7; 51.
S x2-L-Phe-L-His-L-Asp(OMe)-OMe:h  0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
( C H , ),,,); 2.8 (d, 2H, C H ,  (Asp)); 3.0 (m, 2 x 2H, C H ,  (Phe) and 
C H ,  (His)); 3.7 and 3 .8~ (2xs ,  2 x 3 H ,  2 x O C H ,) ;  4.0 (t, 2H, 
C H .O );  4.2-4.9 (m, 3H, 3 x CH); 5.7 (d, 1H, NH (carbamate));  6.8 
and 7.5 (2 x s, 2 x 1H, 2 x CH (Im)); 7.25 (s, 5H, ArH);  7.7 (2 x d, 
2 x  1H, 2 x N H ) ;  8.0 (s (br), 1H, NH (Im)) ppm; - 2 4 . 8 ° ;  128.8; 
55.
S i2-L-Phe-L-His-L-Thr-OMe: 'H N M R  (CD Cl,  and C D ,O D ,  1:1 
(v/v)): 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 23H, ( C H , ) 10 and C H ,  (Thr));
3.0 (m, 4H, C H ,  (Phe) and C H ,  (His)); 3.7 (s, 3H, O C H ,) ;  4.0 (m, 
3H, C H .O  and C H O H  (Thr))- 4.2-5.0 (m, 3 x  1H, 3 x C H ) ;  6.7 
and 7.4 (2 x s, 2 x l H ,  2 x CH (Im)); 7.2 (s, 5H, ArH) ppm;
-  13.3°; 92.2; 51.
S i2-L-Phe-L-His-L-Leu-OMe: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of S l2-L-Phe-L-His-L-
-Leu-0M e;  + 3 .9 ° ;  121.4; 60.
N -(Dodecycloxycarbonyl)-(L-phenylalanyl)-L-histidyl-L- (or D-) X -O H  
( S X2-L-Phe-L-His-t.- (or D-) X-OH). Deprotection of  the correspond­
ing methyl esters was performed in aqueous ethanol using NaOH. 
The crude product was recrystallized from acetone. The final yields 
amounted to 70%. IR (KBr): 1685 c m -1  (CO carbamate);  1650 
c m " 1 (broad; CO amide) unless noted otherwise. 'H N M R  
(methanol-i/4 ); [cx]oV(c 1 0 , methanol); m.p./cC. 
S^-L-Phe-L-His-Gly-OH:  5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
( C H , ) m); 3.0 (2 x d (dist), 4H, C H ,  (Phe) and C H ,  (His)); 3.9 (t, 
2H, C H , 0 ) ;  4.0 (s (br), 2H, C H ,  (Gly)); 4.2-4.8 (m, 2H, 2 x CH);
6.9 and 8.1 (2 x s, 2 x  1H, 2 x CH (Im)); 7.2 (s, 5H, ArH) ppm;
-  1.4°; 205.9.
S ,2-L-Phe-L-His-L-Ala-OH: 5 0.9 (t, 3H, C H ,) ,  1.3 (m, 23H, 
( C H , ) 10 and C H ,  (Ala)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  (His));
3.9 (t, 2H, C H , 0 ) ;  4.2-4.S (m, 3H, 3 x C H ) ;  7.0 and 8.0 ( 2 x s ,  
2 x  1H, 2 x CH (Im)); 7.1 (s, 5H, ArH) ppm; + 5 .6 ° ;  206.1.
S ]2-L-Phe-L-His-L-Abu-OH: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of S  l2-L-Phe-L-His-L- 
-Ala-OH  with the exception: 5 0.9 ( 2 x t ,  2 x 3 H ,  2 x C H , )  ppm; 
+ 4.1; 196.1. IR (KBr): 1685 c m -1 (CO carbamate);  1640 c m " 1 
(CO amide).
S ]2-L-Phe-L-His-L-Nva-OH: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of S l2-L-Phe-L-His-L- 
-Abu-OH\ + 4.1 °; 195.7°C. IR (KBr): 1685 c m " 1 (CO carbamate);  
1640 cm -  1 (CO amide).
S^-L-Phe-L-His-L-Leu-OH:  (m, 9H, 3 x C H , ) ;  1.3 (m, 23H, 
(C H ,) ,„  and C H .C H  (Leu)); 3.0 ( 2 x d  (dist), 2 x 2 H ,  C H .  (Phe) 
and C H ,  (His)); 3.9 (t, 2H, C H .O ) ;  4.2-4.8 (m, 3H, 3 x CH);  7.1 
and 8.1 (2 x s, 2 x 1H, 2 x CH (Im)); 7.1 (s, 5H, ArH) ppm; -  0.2°;
185.5. IR (KBr): 1685 c m ' 1 (CO carbamate);  1640 m _I (CO 
amide).
S ]2-L-Phe-L-His-D-Leu-OH: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of the diastereomeric 
S l2-L-Phe-L-His-L-Leu-OH  compound; - 5 . 2 ° ;  167.2. IR (KBr): 
1685 c m " 1 (CO carbamate);  1640 c m -1 (CO amide).
S , -,-L-Phe-L-His-L-Phe-OH: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
(C H .),,,); 3.0 (m, 6 H, 3 x C H ,) ;  3.9 (t, 2H, C H .O ) ;  4.2-4.9 (m, 3H,
3 x CH); 7.0 and 8.1 (2 x s, 2 x l H ,  2 x CH (Im)); 7.2 (s, 10H, 
2 x A r H )  ppm; + 7 .5 ° ;  169.6 IR (KBr): 1685 c m ' 1 (CO car­
bamate); 1645 c m -1  (CO amide).
S n -L-Phe-L-His-L-Trp-OH: 5 0.9 (t, 3H, C H , ;  1.3 (m, 20H, 
( C H , ) 10); 3.0 (m, 6 H, 3 x C H ,) ;  3.9 (t, 2H, C H , 0 ) ;  4.2-4.8 (m, 3H,
3 x CH); 7.0 and 8.0 (2 x s, 2 x 1H, 2 x CH (Im)); 7.2 (s, 5H, ArH);
6 .8-7.7 (m, 5H, 5 x CH (indolyl)) ppm; + 3 .4 ° ;  146.4. IR (KBr): 
1685 c m -1  (CO carbamate);  1640 m _l (CO amide).
S i2-L-Phe-L-His-L-Ile-OH: The 'H  N M R  spectrum of this 
compound closely resembles the spectrum of the S l2-L-Phe-L- 
-His-L-Leu-OH  compound; + 2 .5 ° ;  166.5. IR (KBr): 1685 c m " 1 
(CO carbamate);  1640 c m -1 (CO amide).
S n -L-Phe-L-His-L-Phg-OH: 5 0.9 (t, 3H, C H 3); 1.3 (m, 20H, 
( C H , ) I0); 3.0 (2 x d (dist); 4H, C H ,  (Phe) and C H .  (His)); 3.9 (t, 
2H, C H .O ) ;  4.2-4.7 (m, 2H, 2 x C H ) ;  5.5 (s, 1H, CH (Phg); 7.0 
and 8.0 (2 x s, 2 x  1H, 2 x CH (Im); 7.2 and 7.3 (2 x s, 2 x 5 H ,
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2 x C 6H 5) ppm; +21.6;  197.0. IR (KBr): 1685 cm 1 (CO car­
bamate);  1645 c m " 1 (CO amide).
S , -,-L-Phe-L-His-L-Thr-OH: 6 0.9 (t, 3H, C H 3); 1.3 (m, 23H, 
( C H , ) I0 and C H ,  (Thr)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  (His));
4.0 (m, 3H, C H , 0  and C H O H );  4.2-4.8 (m, 3H, 3 x CH); 7.0 and
8.1 ( 2 x s ,  2 x  1H, 2 x CH (Im)); 7.2 (s, 5H, ArH) ppm; + 1.5°;
174.5.
S n -L-Phe-L-His-L-Pro-OH: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
( C H , ) I0); 2.0 (m, 4H, 2 x C H ,  (Pro)); 3.0 (m, 4H, C H ,  (Phe) and 
C H ,  (His)); 3.9 (t, 2H, C H , 0 ) ;  3.65 (t, 2H, C H ,  (Pro)); 4.2-4.7 (m, 
3H, 3 x CH);  7.0 and 8.1 (2 x s, 2 x 1H, 2 x CH (Im)); 7.2 (s, 5H, 
ArH) p p m ; -  18.2°; 145.9.
S n -L-Phe-L-His-L-Asp-OH: 5 0.9 (t, 3H, C H 3); 1.3 (m, 20H, 
( C H , ),,,); 2.6 (d (dist), 2H, C H ,  (Asp)); 3.0 (m, 4H, CH (Phe) and 
C H ,  (His)); 3.9 (t, 2H, C H , 0 ) ,  4.1-4.8 (m, 3H, 3 x C H ) ;  7.1 and
8.1 ( 2 x s ,  2 x  1H, 2 x CH (Im)); 7.2 (s, 5H, ArH) ppm; + 6 .8 °; 
215.0.
N-(Dodecyloxycarbonyl)-(L-phenylalanyl)-L-histidine methylamide 
( S 12-i -Phe-L-His-NMA); N -(Butyloxycarbonyl)-(L-phenylalanyl)-L- 
-histidine methylamide (S4-L-Phe-L-His-NMA). These compounds 
were prepared by coupling methylamine to the corresponding di­
peptides (see Ref. 1 for the synthesis of these dipeptides) with the 
aid of 1,3-dicyclohexylcarbodiimide in D M F  according to a pub­
lished m ethod25,26. The crude product was purified by column 
chromatography (Silica 60: C H C l , /C H ,O H ,  10:1 v/v) and sub­
sequent recrystallization from acetone. The final yields amounted 
to approximately 40%. TLC: Rt 0.35 (Silica, C H C l , /C H ,O H ,  
10:1 v/v) for both compounds.
S^-L-Phe-L-His-NM A:  'H  N M R  (CDC1,): 5 0.9 (t, 3H, C H ,) ;  1.3 
(m, 20H, (C H 2),„); 2.55 (s, 3H, N C H ,  j; 3.0 (2 x d (dist); 2 x 2 H ,  
C H ,  (Phe) and C H ,  (His)); 4.3 and 4.5 (2 x t, 2 x 1H, 2 x C H ); 7.25 
(s, 5H, ArH); 6.8 and 7.4 (2 x s, 2 x 1H, 2 x CH (Im)) ppm;
-  13.8° (c 1.0, methanol);  m.p. 142.5°C. IR (KBr): 1690 (CO car­
bamate);  1650 (CO amide) c m “ 1.
S-4-L-Phe-L-His-NMA: 'H  N M R  (CDC1,): 5 0.9 (t, 3H, C H 3); 1.3 
(m, 4H, (C H ,) , ) ;  2.55 (s, 3H, N C H 3); 3.0 (2 x d (dist); 2 x 2 H ,  
C H : (Phe) and C H ,  (His)); 4.3 and 4.5 (2 x t, 2 x 1H, 2 x CH); 7.25 
(s, 5H, ArH); 6.8 and 7.4 (2 x s, 2 x 1H, 2 x CH (Im)) ppm; [a]f”
-  15.8° (c 1.0, methanol);  m.p. 111.1 °C. IR (KBr): 1690 (CO car­
bamate);  1650 (CO amide) c m - 1 .
N -(AIkyloxycarbonyl)-(L-phenylalanyl)-L-hystidyl-L-leucine methyl es­
ter (Sn-L-Phe-L-His-L-Leu-0Me); N -(Benzy>loxycarbony>l)-(l-pheny7- 
alanyl)-L-histidyl-L-leucine methyl ester (Z-L-Phe-L-His-L-Leu-OMe); 
N-(Alkyloxycarbonyl)-(L-phenylalanyl)-L-histidyl-L-alanine methyl 
ester (S n-L-Phe-L-His-L-Ala-OMe). These compounds were prepared 
and purified as described for the S x2-L-Phe-L-His-L-Leu-OMe and 
S  x2-L-Phe-L-His-L-Ala-OMe compounds. The final yields amounted 
to 60-70% . IR (KBr): 1745 (CO ester); 1695 (CO carbamate);  
1650 (CO amide) c m -1  unless noted otherwise. 'H N M R  
(CDC1,); M d / U ’ 10, methanol);  m.p./cC.
S^-L-Phe-L-His-L-Leu-OMe: 5 1.0 (m, 9H, 3 x C H 3); 1.5 (m, 3H, 
C H ,C H  (Leu)); 3.1 (2 x d (dist), 2 x 2 H ,  C H ,  (Phe) and C H ,  
(His)); 3.65 (s, 3H, O C H ,) ;  4.0 (q, 2H, C H , 0 ) ;  4.2-4.9 (m, 3H,
3 x CH); 5.4 (d, 1H, NH (carbamate));  6.7 and 7.4 (2 x s, 2 x 1H, 
2 x CH (Im)); 7.2 (s, 5H, ArH); 7.2 and 7.5 (2 x d, 2 x 1H, 2 x NH);
7.9 (s (br), 1H, NH (Im)) ppm; - 2 8 . 0 ° ;  48.5. 
S A-L-Phe-L-His-L-Leu-OMe: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of S X2-L-Phe-L-His-L-
- L eu -0  Me\ - 2 2 . 2 ° ;  51.7.
S (-L-Phe-L-His-L-Leu-OMe: The 'H N M R  spectrum closely resem­
bles the spectrum of S x2-L-Phe-L-His-L-Leu-OMe\ - 2 1 . 8 ° ;  72.0. 
Z-L-Phe-L-His-L-Leu-OMe: 5 0.9 (2 x d, 2 x 3H, 2 x C H ,  (Leu)); 1.5 
(m, 3H, C H ,C H  (Leu)); 3.1 (2 x d (dist); 2 x 2 H ,  C H ,  (Phe) and 
C H ,  (His)); 3.6 (s, 3H, O C H ,) ;  4.2-5.0 (m, 3 x 1H, 3 x CH); 4.9 (s, 
2H, C H , 0 ) ;  5.8 (d, 1H, NH (carbamate));  6.7 and 7.7 (2 x s,
2 x 1H, 2 x CH (Im)); 7.1 and 7.2 (2 x s, 2 x 5H, 2 x ArH); 7.7 and
7.9 ( 2 x d ,  2 x l H ,  2 x N H ) ;  8.2 (s (br), 1H, NH (Im)) ppm;
-  17.2°; 51.5.
S,-L-Phe-L-His-L-Ala-OMe: 5 1.0 (t, 3H, C H ,) ;  1.45 (d, 3H, C H 3 
(Ala)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  (His)); 3.7 (s, 3H, O C H ,) ;
4.0 (q, 2H, C H , 0 ) ;  6.7 and 7.4 (2 x s, 2 x 1H, 2 x CH (Im)); 7.2 (s, 
5H, ArH) ppm; - 3 8 . 2 ° ;  111.1. IR (KBr): 1690 c m " 1 (CO car­
bamate).
S 4-L-Phe-L-His-L-Ala-OMe: 5 1.0 (m, 7H, C H ,  (C H , ) , ) ;  1.45 (d, 
3H, CH., (Ala)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  (His)); 3.7 (s, 3H,
O C H ,) ;  4.0 (t, 2H, C H , 0 ) ;  4.2-4.9 (m, 3H, 3 x CH);  6.7 and 7.4 
(2 x s, 2 x 1H, 2 x C H  (Im)); 7.2 (s, 5H, ArH) ppm; - 3 3 . 8 ° ;  124.2. 
IR (KBr): 1690 cm 1 (CO carbamate).
S (-i.-Phe-L-His-L-Ala-OMe: The 'H N M R  and IR spectra of this 
compound closely resemble the spectra of S X^ -L-Phe-L-His-L-Ala-
-OMe\ - 3 2 . 0 ° ;  138.2.
N-(Dodecyloxycarbonyl)-(L-phenylalanyl)-L-histidyl-L-X-L- (or D-) 
Y-OMe (X and Y are amino acid residues). The tetrapeptides were 
prepared from the corresponding tripeptidcs and the methyl ester 
of Y in D M F  with the aid of 1,3-dicyclohexylcarbodiimide accord- 
ing to a published m ethod— . The crude products were purified 
as described for the corresponding tripeptide methyl esters. The 
final yields amounted to 50 -60% .  TLC: R( 0.35 (Silica, 
C H C l , /C H ,O H ,  10:1 v/v) for all compounds. 'H N M R  
(C D C l , /C D ,O D ,  1:1 v/v) unless noted otherwise; [ot]f”/(c 1.0, 
methanol); m.p./cC; yield/%; IR (KBr): CO ester, CO carbamate,  
CO amide/cm ‘.
S^-L-Phe-L-His-L-Leu-L-Leu-OMe:  'H  N M R  (CDC1,): 5 0.9 (m, 
15H, 5 x C H ,); 1.1-1.9 (m, 26H, ( C H , ) 10 and 2 x C H , C H  (Leu));
3.0 (m, 4H, C H ,  (Phe) and C H ,  (His)); 3.55 (s, 3H, O C H ,) ;  3.9 (t, 
2H, C H , 0 ) ;  4A -4 .1  (m, 4H.‘ 4 x C H ) ;  5.5 (d, 1H, NH (car­
bamate)); 6.6 and 7.3 ( 2 x s ,  2 x l H ,  2 x CH (Im)); 7.1 (m, 5H. 
ArH); 7.0-7.5 (m, 3H, 3 x N H ) ;  8.7 (s (br), 1H, NH (Im)) ppm;
-  15.3°; 70.6; 62; 1740, 1690, 1645.
S x2-L-Phe-L-His-L-Ala-L-Leu-OMe: 5 0.9 (m, 9H, 3 x CH,) ;  1.3 and 
1.5 (m, 26H, ( C H , ) , 0 and C H C H ,  (Leu) and C H ,  (Ala)); 3.0 (m, 
4H, C H ,  (Phe) and C H ,  (His)); 3.6 (s, 3H, O C H ,) ;  3.9 (t, 2H, 
C H , 0 ) ;  4 .2 -4 .8 (m, 4H, 4 x C H ); 6.7 and 7.4 (2 x s, 2 x 1H, 2 x CH 
(Im)); 7.1 (s, 5H, ArH) ppm; - 3 0 . 0 ° ;  75.0; 60; 1745, 1690, 1650. 
S , 2-L-Phe-L-His-L-A la-L-A la -0  M e : 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 26H, 
( C H , ) ln and 2 x C H ,  (Ala)); 3.0 (m, 4H, C H ,  (Phe) and C H .  
(His)); 3.6 (s, 3H, O C H ,) ;  3.9 (t, 2H, C H , 0 ) ;  4.2-4.S (m, 4H_.
4 x CH); 6.7 and 7.4 (2 x s, 2 x 1H, 2 x CH ( Im)); 7.2 (s, 5H, A r H ) 
ppm; - 3 2 . 5 ° ;  86.2; 55; 1745, 1690, 1650.
S x2-L-Phe-i.-His-L-Leu-L-Ala-OMe: 5 0.9 (m, 9H, 3 x C H ,) ;  1.3 (m, 
29H, (C H , ) 10 and C H ,  (Ala) and 2 x C H ,  (Leu)); 3.0 (m, 4H, C H .  
(Phe) and C H ,  (His)); 3.7 (s, 3H, O C H ,) ;  4.0 (t, 2H, C H , 0 ) ;
4.1-4.8 (m, 4H, 4 x CH); 6.7 and 7.4 (2 x s, 2 x 1H, 2 x CH (Im));
7.2 (s, 5H, ArH) ppm; - 2 8 . 7 ° ;  79.2; 57; 1740, 1690, 1645.
5  l2-L-Phe-L-His-L-Leu-D-Leu-OMe: The 'H N M R  spectrum of this 
compound closelv resembles the spectrum of S X^ -L-Phe-L-His-L- 
-Leu-L-Leu-OMe\ - 0 . 9 ° ;  65.8; 49; 1745, 1690, 1650.
S x2-L-Phe-L-His-i.-Ala-D-Ala-OMe: The 'H N M R  and IR (KBr)  
spectra of this compound closely resemble the spectra of S x2-l-  
-Phe-L-H is-L-A la-L-A la -0  Me\ - 5 . 8 ° ;  83.0; 51.
N-(Dodecyloxycarbonyl)-(L-phenylalanvl)-L-histidyl-L-leucyl-L-leucyl- 
-L-leucine methyl ester ( S x2-L-Phe-t.-His-L-Leu-L-Leu-L-Leu-OMe); 
N-(dodecyloxycarbonvl)-(L-phenylalanyl)-L-histidyl-L-alanyl-L-alanyl- 
-L-alanine methyl ester ( S x2-L-Phe-L-His-L-Ala-L-Ala-L-Ala-OMe). 
These compounds were prepared from the corresponding tetra­
peptides S x2-L-Phe-L-His-L-Leu-L-Leu-OH  and S l2-L-Phe-L-His-L- 
-Ala-L-Ala-OH  and H-L-Leu-OMe • HC1 and H-L-Ala-OMe • HC1 
with the aid of 1,3-dicyclohexylcarbodiimide in D M F  according to 
a published m ethod25,26. The crude products were purified as 
described for the tripeptide methyl esters. The final yields 
amounted to approximately 55%. TLC: R t• 0.35 (Silica, 
C H C 1, /C H ,O H , 10:1 v/v) Yor both compounds. 'H N M R  
(C D C l , /C D ,O D ,  1:1 v/v); [oc]d/(c 1.0, methanol); m.p./cC; IR 
(KBr): CO ester, CO carbamate,  CO am id e /cm - 1 .
S ]2-L-Phe-L-His-L-Leu-L-Leu-L-Leu-OMe: 5 0.9 (m, 21H, 7 x C H ,) ;
1.3 and 1.6 (m, 29H, (C H ,) ,„  and 3 x C H ,C H  (Leu)); 3.0 (m, 4H. 
C H ,  (Phe) and C H ,  (His)j; 3.7 (s, 3H, O C H ,) ;  3.9 (t, 2H, C H , 0 ) ;
4.1-4.7 (m, 5H, 5 x C H ) ;  6.75 and 7.45 (2 x s, 2 x l H ,  2 x CH 
(Im)); 7.2 (s, 5H, ArH) ppm; - 2 2 . 9 ° ;  97.8; 1745, 1690, 1650.
S x2-L-Phe-L-His-L-Ala-L-Ala-L-Ala-OMe: 5 0.9 (t, 3H, C H ,) ;  1.3 (m, 
29H, (CH,) , , ,  and 3 x C H ,  (Ala)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  
(His)); 3.6“ (s, 3H, O C H ,) ;  3.9 (t, 2H, C H , 0 ) ;  4.2-4.8 (m, 5H^ 
5 x CH); 6.7 and 7.4 (2 x  s, 2 x  1H, 2 x  CH (Im)); 7.2 (s, 5H, Ar H)  
ppm; - 3 6 . 2 ° ;  87.4; 1745, 1690, 1650.
N-(Alkoxycarbonyl)-L-(phenylalanyl)-L-histidyl-L-leucine (Sn-L-Phe-L- 
-His-L-Leu-OH); N-(benzyloxvcarbonyl)-L-(phenylalanyl)-L-histidyl-L- 
-leucine (Z-L-Phe-L-His-L-Leu-OH); N-(alkoxycarbonyl)-L-(phenyl- 
alanyl)-L-histidyl-L-alanine (S u-L-Phe-L-His-L-Ala-OH). The corre­
sponding methyl esters were deprotected as described for the 
S l2-L-Phe-L-His-L-X-OH  compounds. The final yields after recrys­
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tallization from acetone amounted to approximately 70%. 
'H  N M R  (C D ,O D ) ;  [ o c ] d / ( c  1.0, methanol);  m.p./°C; IR (KBr): 
CO carbamate ,  CO amide/cm _ l .
S^-L-Phe-L-His-L-Leu-OH: 8 1.0 (m, 9H, 3 x C H , ) ;  1.3 (m, 3H, 
C H X H  (Leu)); 3.0 (m, 4H, C H .  (Phe) and C H ,  (His)); 4.0 (q, 2H, 
C H .O ) ;  4 .2 -4 .8 (m, 3H, 3 x CH); 7.0 and 8.0 (2 x s, 2 x 1H, 2 x CH 
(Im)); 7.15 (s, 5H, Ar H)  ppm; - 2 . 9 ° ;  258.7 (dec.); 1685, 1645. 
S 4-L-Phe-L-His-L-Leu-0H : The 'H N M R  spectrum of this 
compound closely resembles the spectrum of S^-L-Phe-L-His-L- 
-Leu-OH\ - 7 . 2 ° ;  238.7; 1685, 1645.
S 6-L-Phe-L-His-L-Leu-0H : The 'H N M R  and IR spectra of this 
compound closely resemble the spectra of S  A-L-Phe-L-His-L-Leu-
-OH\ - 0 . 8 ° ;  190.3.
Z-L-Phe-L-His-L-Leu-OH: 5 1.0 (2 x d, 6 H, 2 x C H , ) ;  1.7 (m, 3H, 
C H X H  (Leu)); 3.1 (111. 4H. C H ,  (Phe) a n d C H ,  (His)); 4 .0 - 4 .8 (m, 
3H,~ 3 x CH); 5.0 (s, 2H, C H , 0 ) ;  7.1 and **7.2 (2 x s, 2 x 5 H ,  
2 x  ArH); 6.9 and 8.1 (2 x s, 2 x 1H, 2 x CH (Im)); -  1.5°; 224.6; 
1690, 1645.
S,-L-Phe-L-His-L-Ala-OH: 8 1.0 (t, 3H, C H ,) ;  1.4 (d, 3H, C H ,  
(Ala)); 3.0 (m, 4H, C H ,  (Phe) and C H ,  (His)); 3.9 (q, 2H, C H , 0 ) ;
4.1-4.8 (m, 3H, 3 x CH); 7.0 and 8.1 (2 x s, 2 x 1H, 2 x CH (Im));
7.2 (s, 5H, ArH) ppm; + 6 .4 : ; 255.1 (dec.); 1685, 1650. 
S 4-L-Phe-L-His-L-Ala-OH: The 'H  N M R  spectrum of this 
compound closely resembles the spectrum of S  ^ -L-Phe-L-His-L- 
-Ala-OH\ + 5 .9 ° ;  254.0 (dec.); 1685, 1650.
S^-L-Phe-L-His-L-Ala-OH: The 'H N M R  and IR spectra of this 
compound closely resemble the spectra of S A-L-Phe-L-His-L-Ala- 
-OH\ + 5 .8 ° ;  236.2.
N-(Dodecyloxycarbonyl)-L-(phenvlalanyl)-L-histidyl-L- (or n-) X - l-  Y- 
-OH ( S i2-L-Phe-L-His-L- (or D-) X -l-Y -O H ).  The corresponding 
methyl esters were deprotected as described for the S,,-L-Phe-L- 
-His-i-X-OH compounds. The final yields after recrvstallization 
from acetone/methanol amounted to approximately 75%. 
'H N M R  (C D ,O D );  [ o ( ] d / ( c  1.0, methanol); m.p./°C; IR (KBr): 
CO carbamate,  CO am ide /cm “ '.
S^-L-Phe-L-His-L-Leu-L-Leu-OH : 5 0.9 (m, 15H, 5 x C H ,) ;  1.3 (m, 
26H, (C H , ) , 0 and 2 x C H X H  (Leu)); 3.0 (m, 4H, C H ,  (Phe) and 
C H ,  (His)); 3.9 (t, 2H, C H , 0 ) ;  4.1-4.7 (m, 4H, 4 x C H ) ;  7.0 and
8.0 (2 x s, 2 x 1H,  2 x CH (Im)); 7.15 (s, 5H, A r H ) ppm; -  19.8°; 
190.6; 1685, 1650.
S l2-L-Phe-L-His-L-Leu-D-Leu-OH: The 'H N M R  spectrum of this 
compound closely resembles the spectrum of S  n -L-Phe-L-His-L- 
-Leu-L-Leu-OH\ - 3 . 9 ° ;  200.6; 1685, 1645.
S i2-L-Phe-L-His-L-Leu-L-Ala-OH: 8 0.9 (m, 9H, 3 x C H , ) ;  1.3 (m, 
26H. (CH.) , , ,  and C H ,C H  (Leu) and C H ,  (Ala)); 3.0 (m, 4H, C H ,  
(Phe) and C H ,  (His));~3.9 (t. 2H, C H , 0 ) ;  4.1-4.7 (m, 4H, 4 x CH);
7.0 and 8.1 (2 x s, 2 x  1H, 2 x CH (Im)); 7.2 (s, 5H, Ar H)  ppm;
-  14.5°; 189.5; 1690, 1645.
S l2-L-Phe-L-His-L-Ala-L-Leu-OH: 8 0.9 (m, 9H, 3 x C H , ) ;  1.3 (m, 
26H, (CH.) , , ,  and C H X H  (Leu) and C H ,  (Ala)); 3.0 (m, 4H, C H ,  
(Phe) and C H ,  (His));~3.9 (t, 2H, C H , 0 ) ;  4.1-4.7 (m, 4H, 4 x CH);
7.0 and 8.0 (2 x s, 2 x  1H, 2 x CH (Im)); 7.2 (s, 5H, Ar H)  ppm;
-  14.2°; 195.2; 1690, 1645.
S^-L-Phe-L-His-L-Ala-L-Ala-OH : 8 0.9 (t, 3H, C H ,) ;  1.3 (m, 20H, 
(C H .) ,„ ) ;  1.4 (2 x d, 2 x 3H. 2 x C H ,  (Ala)); 3.1 (m, 4H, C H ,  (Phe) 
and C H ,  (His)); 3.95 (t, 2H, C H .O );  4.2-4.8 (m, 4H, 4 x CH); 7.1 
and 8.1 ( 2 x s ,  2 x l H ,  2 x CH (Im)); 7.15 (s, 5H, ArH) ppm;
-  11.5°; 231.7; 1685, 1645.
S i2-L-Phe-L-His-l-Ala-D-Ala-OH: The 'H N M R  and IR (KBr)  
spectra of this compound closely resemble the spectra of S n -L- 
-Phe-L-His-L-Ala-L-Ala-OH\ + 3 .4 ° ;  222.4.
N-(Dodecycloxycarbonyl)-(L-phenylalanyl)-L-histidyl-L-leucyl-L-leucyl- 
-t.-leucine ( S i2-L-Phe-L-His-L-Leu-L-Leu-L-Leu-OH); N -(dodecyclo- 
carbonyl)-(L-phenylalanyl)-L-histidyl-L-alanyl-L-alanyl-L-alanine ( S ]2- 
-L-Phe-L-His-L-Ala-L-Ala-L-Ala-OH). The corresponding methyl 
esters were deprotected as described for the S  X2-L-Phe-L-His-L- 
-X-OH  compounds. The final yields after recrystallization from 
acetone amounted to aprroximately 70%. 'H N M R  (C D ,O D );  
[oc]p/(c 1.0, methanol); m.p./°C; IR (KBr): CO carbamate ,  CO 
amide/cm ~
S x2‘L-Phe-L-His-L-Leu-L-Leu-L-Leu-OH: 8 0.9 m, (21H, 7 x C H , ) ;
1.3 and 1.7 (m, 29H, (C H ,)„ ,  and 3 x C H X H  (Leu)); 3.1 (m, 4H, 
C H ,  (Phe) and C H ,  (His*)); 3.9 (t, 2H, C H , 0 ) ;  4.1-4.7 (m, 5H,
5 x CH); 7.0 and 8.0 (2 x s, 2 x 1H, 2 x CH (Im)); 7.15 (s, 5H, Ar H)  
ppm; - 1 6 . 5 ° ;  186.0; 1685, 1650.
S i2-L-Phe-L-His-L-Ala-L-Ala-L-Ala-OH: 8 0.9 (t, 3H, C H ,) ;  1.3 (m,
29H, (C H , ) , 0 and 3 x C H ,  (Ala)); 3.1 (m, 4H, C H ,  (Phe) and C H ,  
(His)); 4 .2 - 4 .8 (m, 5H, 5 x C H ) ;  7.1 and 8.1 ( 2 x  s~ 2 x  1H, 2 x CH 
(Im)); 7.15 (s, 5H, Ar H)  ppm; - 2 2 . 7 C; 236.0; 1685, 1645.
N - A c v I - l -  (or D-) phenylalanine 4-nitrophenvl ester f(C n-L- (or D-) Phe- 
-ONp (n = 2. 4, 7. 12, 16)]. The enantiomeric substrates were pre­
pared and purified as described for the C,,-L- (or D -)  Phe-ONp 
substrates in our previous p a p e r1. 'H N M R  (CDC1,); IR (KBr): 
CO ester, CO amide, N O ,  ( 3 x ) / c m _ l ; [ot]p/(c 1.0, CHC1,); 
m.p./°C.
C,-/.- (or n-) Phe-ONp: 8 2.1 (s, 3H, C H ,C O );  3.2 (d, 2H, C H ,) ;  5.0 
(2~x t, 1H. CH); 5.8 (d, 1H, NH) ;  7.0 and 8.1 (2 x d, 2 x 2 H ,  
A rN O ,) ;  7.1 (m, 5H, Ar H)  ppm; 1755, 1635, 1525, 1490, 1347; l :
-  18.5% 139.7; n: + 18.2°; 138.4.
Ca-l - (or D-) Phe-ONp: 8 0.95 (t, 3H, C H ,) ;  1.3 (m, 2H, C H ,) ;  2.2 
(t, 211, C H ,C O );  3.2 (d, 2H, C H ,) ;  5.0 (2 x t, 1H, CH); 5.9 (d, 1H, 
N H ); 7.0 and 8.1 (2 x d, 2 x 2H, A rN O ,) ;  7.1 (m, 5H, Ar H)  ppm; 
IR (KBr): as described for the C , , - l -  (or n-) Phe-ONp compounds;  
/,: -  14.2°; 131.5; d :  + 14.0°; 130.1.
C7-l - (or n-) Phe-ONp: The 'H N M R  and IR spectra of these 
compounds closely resemble the spectra of  C,,-L- (or D-) Phe-ONp\ 
l : -  12.7°; 119.0; n: + 12.1°; 119.7.
C u -L- (or D-) Phe-ONp: The 'H N M R  and IR spectra of these 
compounds closely resemble the spectra of C ,,-/-- (or D-) Phe-ONp; 
/.: - 9 . 6 ° ;  101.5; d : + 9 .4 ° ;  102.0.
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